DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE: 5,305 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
5,305
Total FAERS Reports
2,936 (55.3%)
Deaths Reported
282
Hospitalizations
5,305
As Primary/Secondary Suspect
13
Life-Threatening
12
Disabilities
Active Ingredient: DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE SULFATE ·
First Report: 20000101 · Latest Report: 20250926
What Are the Most Common DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE Side Effects?
#1 Most Reported
Death
2,780 reports (52.4%)
#2 Most Reported
Product use in unapproved indication
211 reports (4.0%)
#3 Most Reported
Off label use
157 reports (3.0%)
All DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,780 | 52.4% | 2,780 | 20 |
| Product use in unapproved indication | 211 | 4.0% | 28 | 15 |
| Off label use | 157 | 3.0% | 8 | 8 |
| Drug ineffective | 137 | 2.6% | 7 | 8 |
| Therapy interrupted | 130 | 2.5% | 5 | 10 |
| Dizziness | 117 | 2.2% | 1 | 11 |
| Product use issue | 114 | 2.2% | 35 | 9 |
| Diarrhoea | 97 | 1.8% | 1 | 9 |
| Fall | 91 | 1.7% | 13 | 29 |
| Inability to afford medication | 86 | 1.6% | 0 | 2 |
| Therapeutic response unexpected | 85 | 1.6% | 4 | 7 |
| Dysphagia | 84 | 1.6% | 9 | 3 |
| Somnolence | 82 | 1.6% | 4 | 8 |
| Nausea | 73 | 1.4% | 0 | 11 |
| Disease recurrence | 72 | 1.4% | 6 | 8 |
| Crying | 66 | 1.2% | 1 | 7 |
| Drug effective for unapproved indication | 66 | 1.2% | 1 | 1 |
| Aggression | 60 | 1.1% | 1 | 6 |
| Agitation | 60 | 1.1% | 7 | 16 |
| Condition aggravated | 60 | 1.1% | 2 | 2 |
Who Reports DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE Side Effects? Age & Gender Data
Gender: 65.4% female, 34.6% male. Average age: 69.5 years. Most reports from: US. View detailed demographics →
Is DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 0 |
| 2001 | 1 | 0 | 0 |
| 2003 | 1 | 0 | 0 |
| 2007 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 0 |
| 2011 | 56 | 2 | 1 |
| 2012 | 51 | 1 | 1 |
| 2013 | 61 | 0 | 3 |
| 2014 | 82 | 3 | 18 |
| 2015 | 147 | 9 | 30 |
| 2016 | 189 | 41 | 27 |
| 2017 | 112 | 54 | 25 |
| 2018 | 171 | 111 | 10 |
| 2019 | 345 | 292 | 10 |
| 2020 | 241 | 220 | 3 |
| 2021 | 193 | 178 | 7 |
| 2022 | 162 | 140 | 8 |
| 2023 | 156 | 107 | 10 |
| 2024 | 161 | 118 | 4 |
| 2025 | 46 | 37 | 2 |
What Is DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 2,689 |
| Affect lability | 2,065 |
| Crying | 85 |
| Dementia | 56 |
| Amyotrophic lateral sclerosis | 54 |
| Depression | 44 |
| Dementia alzheimer's type | 43 |
| Anxiety | 33 |
| Craniocerebral injury | 33 |
| Agitation | 29 |
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE vs Alternatives: Which Is Safer?
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE vs DEXTROMETHORPHAN\GUAIFENESIN
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE vs DEXTROSE
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE vs DEXTROSE\DEXTROSE
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE vs DEXTROSE\DEXTROSE\DOBUTAMINE\DOBUTAMINE
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE vs DEXTROSE\HEPARIN
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE vs DEXTROSE\LIDOCAINE
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE vs DEXTROSE\SODIUM
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE vs DIACETYLMORPHINE
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE vs DIAMORPHINE
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE vs DIATRIZOATE MEGLUMINE\DIATRIZOATE
Official FDA Label for DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE
Official prescribing information from the FDA-approved drug label.